| Crosstalk Between The Androgen Receptor And β-Catenin In Castrate-Resistant Prostate Cancer (Medical News Today) |
|
|
UroToday.com - The development of therapeutics for castration resistant prostate cancer depends on understanding the mechanism(s) involved in hormonal progression. The androgen receptor is a transcription factor that is important in the development of both the prostate and prostate cancer. |